<SEC-DOCUMENT>0001974158-24-000085.txt : 20241018
<SEC-HEADER>0001974158-24-000085.hdr.sgml : 20241018
<ACCEPTANCE-DATETIME>20241018174212
ACCESSION NUMBER:		0001974158-24-000085
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20241018
DATE AS OF CHANGE:		20241018

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Enliven Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001672619
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				811523849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-39247
		FILM NUMBER:		241381582

	BUSINESS ADDRESS:	
		STREET 1:		6200 LOOKOUT ROAD
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		720-647-8519

	MAIL ADDRESS:	
		STREET 1:		6200 LOOKOUT ROAD
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IMARA Inc.
		DATE OF NAME CHANGE:	20160419

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lyssikatos Joseph P
		CENTRAL INDEX KEY:			0001967150
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		6200 LOOKOUT ROAD
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001967150</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001672619</issuerCik>
      <issuerName>Enliven Therapeutics, Inc.</issuerName>
      <secFileNumber>001-39247</secFileNumber>
      <issuerAddress>
        <com:street1>6200 LOOKOUT ROAD</com:street1>
        <com:city>BOULDER</com:city>
        <com:stateOrCountry>CO</com:stateOrCountry>
        <com:zipCode>80301</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>720-647-8519</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Lyssikatos Joseph P</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Jefferies LLC</name>
        <address>
          <com:street1>520 Madison Ave</com:street1>
          <com:street2>4th Fl</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>65000</noOfUnitsSold>
      <aggregateMarketValue>1821300.00</aggregateMarketValue>
      <noOfUnitsOutstanding>47000000</noOfUnitsOutstanding>
      <approxSaleDate>10/18/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>06/12/2019</acquiredDate>
      <natureOfAcquisitionTransaction>Founder Shares</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Enliven Therapeutics</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>65000</amountOfSecuritiesAcquired>
      <paymentDate>06/12/2019</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Joseph Lyssikatos</name>
        <address>
          <com:street1>6200 Lookout Road</com:street1>
          <com:street2>1st Fl</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics Inc.</securitiesClassTitle>
      <saleDate>08/29/2024</saleDate>
      <amountOfSecuritiesSold>12000</amountOfSecuritiesSold>
      <grossProceeds>269840.88</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Joseph Lyssikatos</name>
        <address>
          <com:street1>6200 Lookout Road</com:street1>
          <com:street2>1st Fl</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics Inc.</securitiesClassTitle>
      <saleDate>10/01/2024</saleDate>
      <amountOfSecuritiesSold>527</amountOfSecuritiesSold>
      <grossProceeds>14512.08</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Joseph Lyssikatos</name>
        <address>
          <com:street1>6200 Lookout Road</com:street1>
          <com:street2>1st Fl</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics Inc.</securitiesClassTitle>
      <saleDate>10/04/2024</saleDate>
      <amountOfSecuritiesSold>7522</amountOfSecuritiesSold>
      <grossProceeds>206936.84</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Joseph Lyssikatos</name>
        <address>
          <com:street1>6200 Lookout Road</com:street1>
          <com:street2>1st Fl</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics Inc.</securitiesClassTitle>
      <saleDate>10/07/2024</saleDate>
      <amountOfSecuritiesSold>2707</amountOfSecuritiesSold>
      <grossProceeds>74727.14</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Joseph Lyssikatos</name>
        <address>
          <com:street1>6200 Lookout Road</com:street1>
          <com:street2>1st Fl</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics Inc.</securitiesClassTitle>
      <saleDate>10/08/2024</saleDate>
      <amountOfSecuritiesSold>13267</amountOfSecuritiesSold>
      <grossProceeds>371024.66</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Joseph Lyssikatos</name>
        <address>
          <com:street1>6200 Lookout Road</com:street1>
          <com:street2>1st Fl</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics Inc.</securitiesClassTitle>
      <saleDate>10/09/2024</saleDate>
      <amountOfSecuritiesSold>37878</amountOfSecuritiesSold>
      <grossProceeds>1066561.91</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>All sales are to be made pursuant to a previously signed/adopted 10b5-1 selling plan dated 06/26/2023, and all representations regarding material non-public information were made as of the adoption of the plan. The shares in this filing will be sold from The Lyssikatos Revocable Trust UAD 12/15/11.</remarks>
    <noticeSignature>
      <noticeDate>10/18/2024</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>06/26/2023</planAdoptionDate>
      </planAdoptionDates>
      <signature>Joseph Lyssikatos</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
